Browsing Tag
Boots
7 posts
Why L’Oréal, Coty and Unilever are betting on affordable fragrance mists
Affordable fragrance mists are gaining ground as L’Oréal, Coty and Unilever introduce new products targeting everyday beauty routines. Stronger mass-market fragrance sales suggest genuine consumer interest, but the commercial opportunity depends on repeat purchasing, margins and whether mists generate additional spending rather than replace traditional perfumes.
October 18, 2026
Weston family to buy Boots for $8.9bn as pharmacy giant changes hands again
Canada’s Weston family and Fairfax Financial are acquiring Boots for $8.9 billion including assumed debt, placing one of Britain’s largest pharmacy and beauty businesses under owners with deep experience across grocery, healthcare and pharmacy retail.
October 11, 2026
Why Fairfax is putting $2.3bn behind Wittington’s $8.9bn Boots takeover
Wittington Investments’ $8.9 billion acquisition of Boots brings one of Britain’s biggest pharmacy and beauty businesses under Canadian ownership, with Fairfax Financial Holdings committing up to $2.3 billion for a 50% equity interest. The strategic fit is compelling, but the transaction puts substantial capital behind a retailer that still needs continued investment in stores, digital commerce and healthcare services.
October 10, 2026
Fairfax commits up to US$2.3bn for 50% of Boots in US$8.9bn Weston partnership
Fairfax Financial Holdings Limited will commit up to US$2.3 billion to acquire 50% of Boots alongside Wittington Investments in a US$8.9 billion transaction that puts operating control with the Weston family.
October 9, 2026
Boots sold for $8.9bn as Weston family makes major return to UK retail
Wittington Investments and Fairfax Financial Holdings are acquiring Boots in an $8.9 billion transaction, putting the UK pharmacy and beauty retailer under owners with deep experience in grocery, pharmacy and consumer retail.
October 9, 2026
SkinBioTherapeutics (LSE: SBTX) is growing again, but will cash last long enough?
SkinBioTherapeutics is growing revenue, but cash and credibility remain tight. New FY2026 guidance will decide whether SBTX can rerate.
July 10, 2026
Legal & General announces £4.8bn buy-in with Boots Pension Scheme
Legal & General Group plc, a renowned financial services firm, has achieved a significant milestone by finalizing a…
November 26, 2023